Trademark: 87837997
Status Date
Monday, January 3, 2022
Filing Date
Friday, March 16, 2018
Published for Opposition
Tuesday, April 7, 2020
Abandoned Date
Monday, January 3, 2022
1 Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research
5 Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Pharmaceutical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Natural biomaterials for augmentation of bone and tissue for medical purposes
Jan 3, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 3, 2022
Abandonment - No Use Statement Filed
May 21, 2021
Notice Of Approval Of Extension Request E-Mailed
May 19, 2021
Extension 2 Granted
May 19, 2021
Extension 2 Filed
May 19, 2021
Teas Extension Received
Dec 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 1, 2020
Extension 1 Granted
Dec 1, 2020
Extension 1 Filed
Dec 1, 2020
Teas Extension Received
Jun 2, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 7, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 7, 2020
Published For Opposition
Mar 18, 2020
Notification Of Notice Of Publication E-Mailed
Mar 2, 2020
Electronic Record Review Complete
Feb 28, 2020
On Hold - Electronic Record Review Required
Feb 25, 2020
Approved For Pub - Principal Register
Feb 1, 2020
Teas/Email Correspondence Entered
Feb 1, 2020
Correspondence Received In Law Office
Jan 28, 2020
Teas Response To Suspension Inquiry Received
Nov 24, 2019
Notification Of Inquiry As To Suspension E-Mailed
Nov 24, 2019
Inquiry To Suspension E-Mailed
Nov 24, 2019
Suspension Inquiry Written
Nov 14, 2019
Suspension Checked ¿ To Attorney For Action
May 14, 2019
Notification Of Letter Of Suspension E-Mailed
May 14, 2019
Letter Of Suspension E-Mailed
May 14, 2019
Suspension Letter Written
May 14, 2019
Teas/Email Correspondence Entered
May 14, 2019
Correspondence Received In Law Office
May 10, 2019
Teas Response To Suspension Inquiry Received
Nov 13, 2018
Notification Of Inquiry As To Suspension E-Mailed
Nov 13, 2018
Inquiry To Suspension E-Mailed
Nov 13, 2018
Suspension Inquiry Written
Nov 5, 2018
Suspension Checked ¿ To Attorney For Action
Nov 1, 2018
Assigned To Lie
Apr 14, 2018
Notification Of Letter Of Suspension E-Mailed
Apr 14, 2018
Letter Of Suspension E-Mailed
Apr 14, 2018
Suspension Letter Written
Apr 6, 2018
Assigned To Examiner
Mar 23, 2018
New Application Office Supplied Data Entered In Tram
Mar 20, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
